Page last updated: 2024-11-01

nifedipine and Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis

nifedipine has been researched along with Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies."5.39Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn. ( Keskin, M; Koklu, E; Koklu, S; Ozkan, KU; Sayar, H, 2013)
"We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies."1.39Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn. ( Keskin, M; Koklu, E; Koklu, S; Ozkan, KU; Sayar, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koklu, E1
Ozkan, KU1
Sayar, H1
Koklu, S1
Keskin, M1

Other Studies

1 other study available for nifedipine and Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis

ArticleYear
Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn.
    Journal of pediatric endocrinology & metabolism : JPEM, 2013, Volume: 26, Issue:11-12

    Topics: Combined Modality Therapy; Congenital Hyperinsulinism; Humans; Infant, Newborn; Male; Nesidioblastos

2013